Disease Modification in Parkinson’s Disease

(46:44)

Parkinson’s Treatment: Disease Modifying vs. Symptomatic | 2019 Udall Center Research Symposium

(34:48)

Scientist Explains: Disease Modifying Agents in Dementia

(4:48)

Disease Modification | Curdin Conrad, MD | Switzerland

(24:19)

Symptom Relief vs. Disease Modification

(1:2)

Therapeutic development 1: Disease modifying trials an overview. (Rallying 2023)

(24:10)

Moving from symptomatic therapy towards disease modification in PD

(6:11)

Rheumatoid arthritis - causes, symptoms, diagnosis, treatment, pathology

(12:28)

Doctor Thinks He Knows What Causes Alzheimer’s, Parkinson’s, and ALS! | Mark Hyman

(56:35)

TELOGEN EFFLUVIUM RECOVERY | WHAT WORKED FOR ME | NO B.S. HAIR REGROWTH TIPS | LAUREN NEWLY

(8:44)

Dr. Daniel Amen: Repair Your Brain With a Healthy Lifestyle

(20:11)

Multiple Sclerosis - How I Knew I Had MS

(17:12)

How CRISPR Changes Human DNA Forever

(4:9)

Biomarkers of Neuroinflammation in Parkinson’s Disease - Full video

(56:6)

Parkinson's Disease Therapeutic Pipeline - Guest Speaker - UF PD Symposium 2023

(50:19)

Why Do 90% Fail at Their Health Goals? It's Not What You're Spending

(11:25)

Actinogen Medical – executive interview

(23:39)

Research Engagement – Is disease modification in Parkinson’s a reality?

(25:2)

What does disease modification mean and what are the implications for MPN patients?

(1:47)

Professor Gary Cutter - 'Designing disease modifying therapy trials in more advanced disease'

(33:57)

Efficacy of Biologics in Terms of True Disease Modification | Ken Gordon, MD | United States

(19:19)

Parkinson's disease modification through c-Abl inhibition

(4:55)

Patricia K. Coyle, MD: Disease-Modification in Multiple Sclerosis

(2:29)

Research connects I Disease-modifying treatments and dementia

(58:19)

Update on Disease Modifying Therapies

(1:1:36)

Expert Perspective | Disease Modification in Polycythemia Vera

(3:39)

Ask the expert: disease modifying drugs

(9:57)

Alzheimer's disease research priorities: disease modification and symptom management

(1:46)